Perrigo Confirms Patent Challenge For Generic Version Of Narcan(R)

DUBLIN, Oct. 26, 2018 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that Adapt Pharma Operations Limited, Adapt Pharma Inc., Adapt Pharma Ltd. and Opiant Pharmaceuticals initiated patent litigation on ... Biopharmaceuticals, Generics, Litigation Perrigo, Adapt Pharma, Narcan, naloxone
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news